NFKB1 and neoplasm: In summary, our results suggest that STAT3 represses NF-κB-dependent CXCL1 expression by sequestering NF-κB in the cytoplasm and mechanistically delineate a novel tumour-suppressive pathway governed by the STAT3–NF-κB–CXCL1 axis.